Amyloidosis - 258 Studies Found

Not yet recruiting : Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis
:
  • Amyloidosis
  • Immunoglobulin Light Chain Deposition

: 2017-04-21
:
  • Drug: Bortezomib Given SC
Completed : Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
: Relapsed or Refractory Systemic Light Chain Amyloidosis
: 2012-08-02
:
  • Drug: IXAZOMIB IXAZOMIB capsul
Completed : The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis
: Primary Systemic (AL) Amyloidosis
: 2014-12-02
:
  • Drug: NEOD001 NEOD001, is a hu
Completed : Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis
: Amyloidosis
: 2011-07-28
: Drug: melphalan, thalidomide and dexamethasone
Completed : Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
:
  • Multiple Myeloma
  • Primary Amyloidosis

: 2008-03-31
:
  • Drug: Melphalan 100 mg/m^2 via
Completed : Collecting Samples From Patients With Primary Systemic Amyloidosis
: Multiple Myeloma
: 2009-05-09
:
  • Genetic: clonality analysis an
Completed : Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2007-10-19
: Biological: Human immune globulin intravenous (IGIV) Analyze the therapeutic potential of human immune g
Recruiting : Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
:
  • Plasma Cell Dyscrasias
  • Monoclonal Gammopathy of Undetermined Significance
  • Drug: Melphalan 100 mg/m2 twic
Completed : High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
: Multiple Myeloma and Plasma Cell Neoplasm
: 1999-11-01
:
  • Biological: filgrastim
  • Drug: melphalan
<<< Previous | Next >>>